Abeona Therapeutics (ABEO) Notes Payables (2014 - 2022)
Abeona Therapeutics (ABEO) posted quarterly Notes Payables of $400000.0 for Q4 2014, up 60.0% quarter-over-quarter from $250000.0 in Q3 2014.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Notes Payables (2014 - 2022) Analysis & Trends
Abeona Therapeutics' Notes Payables history runs 1 years deep, the most recent figure standing at $400000.0 for Q4 2014.
- In Q4 2014, Notes Payables changed N/A year-over-year to $400000.0; the TTM figure through Dec 2014 stood at $400000.0 (changed N/A YoY), while the FY2014 annual figure was $400000.0, changed N/A from the prior year.
- Notes Payables for Q4 2014 stood at $400000.0, up from $250000.0 in the prior quarter.
- The five-year high for Notes Payables was $400000.0 in Q4 2014, with the low at $250000.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 4.92 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 4.60 Mn |
| Sep 30, 2021 | 20.00 Mn |
| Jun 30, 2021 | 34.43 Mn |
| Mar 31, 2021 | 32.93 Mn |
| Dec 31, 2020 | 31.52 Mn |
| Sep 30, 2020 | 30.13 Mn |
| Jun 30, 2020 | 28.80 Mn |
| Mar 31, 2020 | 28.00 Mn |
| Dec 31, 2019 | 27.40 Mn |
| Sep 30, 2019 | 10.00 Mn |
| Dec 31, 2018 | 10.00 Mn |
| Dec 31, 2014 | 400,000.00 |
| Sep 30, 2014 | 250,000.00 |